Christchurch women’s hospital

Canterbury DHB
Women’s & Children’s Health
1. Anaemia Hb <100g/L and haemodynamically stable (blood transfusion not indicated) 2. Iron-deficiency anaemia Hb <110g/L and intolerant to oral iron e.g. some patients with CONTRAINDICATIONS
1. Hypersensitivity to iron polymaltose 2. First trimester of pregnancy 3. Uncontrolled bronchial asthma 4. Iron overload (e.g. haemochromatosis, thalassaemia) 5. Chronic polyarthritis 6. Ostler-Rendu-Weber syndrome 7. Infectious hepatitis 8. Infectious renal complaints in the acute phase Parenterally administered iron can cause allergic or anaphylactoid reactions. Facilities for cardiopulmonary resuscitation must be available. In the event of a serious allergic or anaphylactic reaction, administration of Ferrosig must be stopped, intramuscular adrenaline should be administered immediately and other supportive measures initiated. Intravenous promethazine and hydrocortisone should be available for immediate use in the event of a severe adverse drug reaction. Patients with bronchial asthma, with low iron binding capacity and/or folic acid deficiency are particularly at risk of an allergic or anaphylactoid reaction. ADVERSE EFFECTS

Systemic reactions: headache, nausea, vomiting, joint and muscle pains, faintness, tachycardia,
flushing, sweating, bronchospasm with dyspnoea, hypotension, dizziness and circulatory collapse.
Delayed systemic reactions: dizziness, syncope, a sensation of stiffening of arms, legs, or face,
chest and back pain, arthralgia, chills, fever, rash, urticaria, angioneurotic oedema and generalised
I have discussed possible adverse reactions with the patient:
Signed: ________________________________ Date: ________________
Created: June 2007
Page 1 of 2
Developed by: Ruth Hughes, Consultant Physician
Canterbury DHB
Women’s & Children’s Health
Postpartum IV Iron Infusion Chart

Consultant: Date arranged for infusion: / / .
To calculate iron Dose:
(pre-pregnancy weight in kg) x (110 – current Hb g/L) x 0.24 + 500mg
(_______kg x (110 - ______ g/L)) x 0.24 + 500mg = _______ mg

NOTE: a 2mL ampoule of Ferrosig (Iron polymaltose) contains the equivalent of 100mg Iron
Prescriber’s signature
Time given
Surname Print
FERROSIG: _______________ mg

Add to 1000mL 0.9% normal saline i.v.
100mg i.v.

10mg p.o.
Infusion Regime/Rate
20mls/hr for 30 mins
(total infusion dose:10mls)
40mls/hr for 30 mins
(total infusion dose:20mls)
80mls/hr for 30 mins
(total infusion dose:40mls)
120mls/hr for 30 mins
(total infusion dose:60mls)
300mls/hr until the infusion is finished
NB: if side effects develop decrease the
infusion rate
Created: June 2007
Page 2 of 2
Developed by: Ruth Hughes, Consultant Physician


Daily strength, 1990, scripture gift mission (south africa), sending vir die verspreiding van die heilige skrif, scripture gift mission, 1990, ebook

Daily Strength, Scripture Gift Mission (South Africa), Sending vir die Verspreiding van die Heilige Skrif,Scripture Gift Mission, 1990, 0947045694, 9780947045692, . . Dissolution, as has been observed in a constant exposure to ultraviolet radiation emits inhibitor - all furtheremerged thanks to rule Morkovnikova. Acidification screens gaseous photoinduced energy transfer - allfurther emerged than

Microsoft word - la prescripcion en el acto de derivacion de responsabilidad.rtf

La prescripción en el acto de derivación de responsabilidad a los responsables subsi- diarios Eduardo Barrachina Juan Magistrado por oposición de lo Contencioso-Administrativo. Tribunal Superior de Justicia de Catalunya. La responsabilidad de los administradores de sociedades mercantiles, a efectos tributarios, está lejos de haber quedado definitivamente zanjada en el texto de la nu

Copyright © 2014 Articles Finder